Acylated Ghrelin is Protective Against 6-OHDA-induced Neurotoxicity by Regulating Autophagic Flux

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894 · see citing works

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135 · see citing works

Pathogenic Lysosomal Depletion in Parkinson's Disease

Dehay, B., Bové, J., Rodríguez-Muela, N., Perier, C., Recasens, A., Boya, P., & Vila, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1920-10.2010 · Cited by 825 · see citing works

Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism

Andrews, Z. B., Erion, D., Beiler, R., Liu, Z.-W., Abizaid, A., Zigman, J., Elsworth, J. D., Savitt, J. M., DiMarchi, R., Tschöp, M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3890-09.2009 · Cited by 289 · see citing works

Tyrosine Hydroxylase and Parkinson’s Disease

Haavik, J., & Toska, K. (1998) · Molecular Neurobiology · doi:10.1007/bf02741387 · Cited by 263 · see citing works

Neuroprotective Effect of Ghrelin in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson’s Disease by Blocking Microglial Activation

Moon, M., Kim, H. G., Hwang, L., Seo, J.-H., Kim, S., Hwang, S., Kim, S., Lee, D., Chung, H., Oh, M. S., et al. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9037-x · Cited by 203 · see citing works

Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK

Wang, X., Wang, X.-L., Chen, H., Wu, D., Chen, J., Wang, X., Li, R., He, J., Mo, L., Cen, X., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.040 · Cited by 182 · see citing works

Ghrelin-AMPK Signaling Mediates the Neuroprotective Effects of Calorie Restriction in Parkinson's Disease

Bayliss, J. A., Lemus, M. B., Stark, R., dos Santos, V. V., Thompson, A., Rees, D. J., Galić, S., Elsworth, J. D., Kemp, B. E., Davies, J. S., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4373-15.2016 · Cited by 161 · see citing works

Neuroanatomical characterization of a growth hormone secretagogue receptor-green fluorescent protein reporter mouse

Mani, B. K., Walker, A. K., López-Soto, E. J., Raingo, J., Lee, C. E., Perelló, M., Andrews, Z., & Zigman, J. (2014) · The Journal of comparative neurology · doi:10.1002/cne.23627 · Cited by 155 · see citing works

Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra

Jiang, H., Li, L.-J., Wang, J., & Xie, J.-X. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.006 · Cited by 144 · see citing works

Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process

Moghadam, A. K., Charsouei, S., Bell, B., & Jabalameli, M. R. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0587-4 · Cited by 137 · see citing works

Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics

Senkevich, K. A., & Gan‐Or, Z. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.11.015 · Cited by 135 · see citing works

Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons

Schapansky, J., Khasnavis, S., DeAndrade, M. P., Nardozzi, J. D., Falkson, S. R., Boyd, J. D., Sanderson, J. B., Bartels, T., Melrose, H. L., & LaVoie, M. J. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.12.005 · Cited by 133 · see citing works

Insights into noncanonical E1 enzyme activation from the structure of autophagic E1 Atg7 with Atg8

Hong, S., Kim, B.-W., Lee, K.-E., Kim, S. W., Jeon, H., Kim, J., & Song, H. K. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2165 · Cited by 100 · see citing works

Reduced autophagy in livers of fasted, fat-depleted, ghrelin-deficient mice: Reversal by growth hormone

Zhang, Y., Fang, F., Goldstein, J. L., Brown, M. S., & Zhao, T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423643112 · Cited by 80 · see citing works

Molecular Events Underlying Parkinson’s Disease – An Interwoven Tapestry

Lim, K., & Zhang, C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00033 · Cited by 79 · see citing works

Ubiquitin and Parkinson's disease through the looking glass of genetics

Walden, H., & Muqit, M. M. K. (2017) · Biochemical Journal · doi:10.1042/bcj20160498 · Cited by 67 · see citing works

Assessments of plasma ghrelin levels in the early stages of Parkinson's disease

Song, N., Wang, W., Jia, F., Du, X., Xie, A., He, Q., Shen, X., Zhang, J., Rogers, J. T., Xie, J., et al. (2017) · Movement Disorders · doi:10.1002/mds.27095 · Cited by 67 · see citing works

Threonine 56 phosphorylation of Bcl-2 is required for LRRK2 G2019S-induced mitochondrial depolarization and autophagy

Su, Y.-C., Guo, X. L., & Qi, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.11.009 · Cited by 65 · see citing works

Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition

Smith, G. A., Jansson, J. P., Rocha, E. M., Osborn, T. M., Hallett, P. J., & Ole Isacson, A. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9435-4 · Cited by 64 · see citing works

Ghrelin Antagonized 1-Methyl-4-Phenylpyridinium (MPP+)-Induced Apoptosis in MES23.5 Cells

Dong, J., Song, N., Xie, J.-X., & Jiang, H. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9162-7 · Cited by 64 · see citing works

Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson’s disease-like motor dysfunction

Suda, Y., Kuzumaki, N., Sone, T., Narita, M., Tanaka, K., Hamada, Y., Iwasawa, C., Shibasaki, M., Maekawa, A., Matsuo, M., et al. (2018) · Molecular Brain · doi:10.1186/s13041-018-0349-8 · Cited by 60 · see citing works

Ghrelin improves vascular autophagy in rats with vascular calcification

Xu, M.-M., Liu, L., Song, C.-F., Chen, W., & Gui, S.-Y. (2017) · Life Science · doi:10.1016/j.lfs.2016.11.025 · Cited by 58 · see citing works

Acylated but not des‐acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's disease

Bayliss, J. A., Lemus, M. B., dos Santos, V. V., Deo, M., Elsworth, J. D., & Andrews, Z. B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13576 · Cited by 56 · see citing works

Assessment of Autophagy in Neurons and Brain Tissue

Benito‐Cuesta, I., Díez, H., Ordóñez‐Gutiérrez, L., & Wandosell, F. G. (2017) · Cells · doi:10.3390/cells6030025 · Cited by 49 · see citing works

Ghrelin signaling in the ventral tegmental area mediates both reward-based feeding and fasting-induced hyperphagia on high-fat diet

Wei, X., Sun, B., Chen, K., Lv, B., Luo, X. M., & Yan, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.001 · Cited by 45 · see citing works

Rotenone Induces the Formation of 4-Hydroxynonenal Aggresomes. Role of ROS-Mediated Tubulin Hyperacetylation and Autophagic Flux Disruption

Bonet‐Ponce, L., Sáez-Atiénzar, S., da Casa, C., Sancho-Pellúz, J., Barcia, J. M., Martínez‐Gil, N., Nava, E., Jordán, J., Romero, F. J., & Galindo, M. F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9509-3 · Cited by 45 · see citing works

Ghrelin prevents 1-methyl-4-phenylpyridinium ion-induced cytotoxicity through antioxidation and NF-kappaB modulation in MES23.5 cells.

Liu, L., Xu, H.-M., Jiang, H., Wang, J., Song, N., & Xie, J.-X. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.11.009 · Cited by 44 · see citing works

Effects of Ghrelin on the Proteolytic Pathways of Alzheimer’s Disease Neuronal Cells

Cecarini, V., Bonfili, L., Cuccioloni, M., Keller, J., Bruce-Keller, A., & Eleuteri, A. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9227-x · Cited by 40 · see citing works

6-Hydroxydopamine induces autophagic flux dysfunction by impairing transcription factor EB activation and lysosomal function in dopaminergic neurons and SH-SY5Y cells

He, X., Yuan, W., Li, Z., Hou, Y., Liu, F., & Feng, J. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.11.017 · Cited by 36 · see citing works

Ghrelin protects adult rat hippocampal neural stem cells from excessive autophagy during oxygen-glucose deprivation

Chung, H., Choi, J., & Park, S. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej17-0281 · Cited by 33 · see citing works

Ghrelin promotes midbrain neural stem cells differentiation to dopaminergic neurons through Wnt/β‐catenin pathway

Gong, B., Jiao, L., Du, X., Li, Y., Bi, M., Jiao, Q., & Jiang, H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29699 · Cited by 29 · see citing works

Ghrelin protects MES23.5 cells against rotenone via inhibiting mitochondrial dysfunction and apoptosis.

Yu, J., Xu, H.-M., Shen, X.-L., & Jiang, H. (2016) · Neuropeptides · doi:10.1016/j.npep.2015.09.011 · Cited by 26 · see citing works

Ghrelin mitigates MPP+-induced cytotoxicity: Involvement of ERK1/2-mediated Nrf2/HO-1 and endoplasmic reticulum stress PERK signaling pathway

Wang, H., Dou, S., Zhu, J., Shao, Z., Wang, C., & Cheng, B. (2020) · Peptides · doi:10.1016/j.peptides.2020.170374 · Cited by 20 · see citing works

The Role of Ghrelin in Senescence: A Mini-Review

Yin, Y., & Zhang, W. (2015) · Gerontology · doi:10.1159/000433533 · Cited by 19 · see citing works

An autophagic mechanism is involved in the 6-hydroxydopamine-induced neurotoxicity in vivo

He, X., Yuan, W., Li, Z., & Feng, J. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.08.006 · Cited by 16 · see citing works

Ghrelin induces autophagy and CXCR4 expression via the SIRT1/AMPK axis in lymphoblastic leukemia cell lines.

Heshmati, M., Soltani, A., Sanaei, M.-J., Nahid-Samiei, M., Shirzad, H., Jami, M., & Ghatrehsamani, M. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109492 · Cited by 16 · see citing works

Effect of ghrelin on activities of some lysosomal hydrolases in rabbits.

Witek, B., Ochwanowska, E., Rafay, J., Kolataj, A., Chrenek, P., Süvegová, K., Jurčí­k, R., Sirotkin, A. V., & Darłak, K. (2005) · PubMed · Cited by 11 · see citing works

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 205 · see citing works

VGF: A prospective biomarker and therapeutic target for neuroendocrine and nervous system disorders

Wang, Y., Qin, X., Han, Y. J., & Li, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113099 · Cited by 33 · see citing works

The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases

Jiao, F., Zhou, B., & Meng, L. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13985 · Cited by 21 · see citing works

Targeting G Protein-Coupled Receptors in the Treatment of Parkinson's Disease.

Jones-Tabah, J. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167927 · Cited by 18 · see citing works

Demystifying the Neuroprotective Role of Neuropeptides in Parkinson’s Disease: A Newfangled and Eloquent Therapeutic Perspective

Behl, T., Madaan, P., Sehgal, A., Singh, S., Makeen, H. A., Albratty, M., Alhazmi, H. A., Meraya, A. M., & BUNGAU, S. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094565 · Cited by 19 · see citing works

Hypoxia-inducible factor-1 as targets for neuroprotection : from ferroptosis to Parkinson’s disease

Wang, C., Lv, S., Zhao, H., He, G., Liang, H., Chen, K., Qu, M., He, Y., & Ou, C. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07832-x · Cited by 18 · see citing works

“Sibling” battle or harmony: Crosstalk between nesfatin-1 and ghrelin

Chen, X., Dong, J., Jiao, Q., Du, X., Bi, M., & Jiang, H. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04193-6 · Cited by 17 · see citing works

Protective role of ghrelin against 6PPD-quinone-induced neurotoxicity in zebrafish larvae (Danio rerio) via the GHSR pathway

Huang, Z., Chen, C., Guan, K., Xu, S., Chen, X., Lin, Y., Li, X., & Shan, Y. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117031 · Cited by 17 · see citing works

Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators

Schmitt, V., Masanetz, R. K., Weidenfeller, M., Ebbinghaus, L. S., Süß, P., Rosshart, S. P., von Hörsten, S., Zunke, F., Winkler, J., & Xiang, W. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114574 · Cited by 16 · see citing works

Biomimetic astrocyte cell membrane-fused nanovesicles for protecting neurovascular units in hypoxic ischemic encephalopathy

Liu, Z., Xia, Q., Wang, C., Xu, J., Tian, K., Wang, Z., Li, L., Li, Y., Shang, H., Liu, Q., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03053-8 · Cited by 11 · see citing works

Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease

Rees, D. J., Beynon, A. L., Lelos, M. J., Smith, G. A., Roberts, L. D., Phelps, L., Dunnett, S. B., Morgan, A. H., Brown, M. R., Wells, T., et al. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01282-9 · Cited by 9 · see citing works

Neuroprotection of Truncated Peptide IIAVE from Isochrysis zhanjiangensis: Quantum Chemical, Molecular Docking, and Bioactivity Studies

Liu, Q., Lin, L., Li, H., & Qian, Z. (2024) · Molecules · doi:10.3390/molecules29030692 · Cited by 6 · see citing works

A novel epitope tag from rabies virus has versatile in vitro applications

Zhang, Y., Zhao, L., Wang, Q., Zhang, Z., Ren, X., Yang, X., Zeng, S., Lv, L., Zhao, L., Su, S., et al. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12546-9 · Cited by 3 · see citing works

Profiling Cysteine Proteases Activities in Neuroinflammatory Cells

Agost-Beltrán, L., Canseco-Rodríguez, A., Schirmeister, T., Rodríguez, S., Sánchez‐Pérez, A. M., & González, F. V. (2024) · ChemMedChem · doi:10.1002/cmdc.202400520 · Cited by 3 · see citing works

Ghrelin-based interventions in preclinical models of Parkinson’s disease: a systematic review

Gouveia, H. J. C. B., dos Santos, O. H., Frasnelli, J., Fisette, A., dos Santos, J. P., Araújo, M. A. D. S., da Silva‐Araújo, E. R., Toscano, A. E., & de Castro, R. M. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150187 · Cited by 2 · see citing works

Essential role of ATG7 in LPS-induced endometrial inflammatory injury in goats

Jiang, T., Yin, X., & Chen, J. (2023) · Animal Diseases · doi:10.1186/s44149-023-00079-7 · Cited by 1 · see citing works

Paeony root prevents 6-hydroxydopamine-induced neurotoxicity by regulating autophagic dysfunction via AKT signaling in Parkinson’s disease models

Choi, Y., Huh, E., Ju, I. G., Lee, H., Kim, J. H., Lee, S., Park, S., Choi, M., Jang, Y. P., Park, H.-J., et al. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01764-x · Cited by 1 · see citing works

Reviving hope: ghrelin’s role in post-cardiac arrest coma management

Qadri, M., & Salomon, I. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002989

Grelina y autofagia: nuevas perspectivas terapéuticas en enfermedades neurodegenerativas

de Guadalajara, U., Ayub-Ayala, M., Pardo‐Peña, K., Ventura-Mejía, C., Salazar‐Sánchez, J. C., & Medina‐Ceja, L. (2025) · e-CUCBA · doi:10.32870/e-cucba.vi25.389

Bi-allelic variants in TBC1D8 result in non-obstructive azoospermia in both humans and micePreprint

Hu, Z., Zeng, J., Wen, M., Zhang, J., Li, Y., Zhao, J. C., Chen, J., Xiao, H., & Huang, H. (2025) · medRxiv · doi:10.1101/2025.10.31.25337980

Integrative role of orexigenic peptides in neuroprotection and neurodegenerative disease modulation

Sopko, Z., Pačesová, A., Železná, B., & Maletínská, L. (2026) · Bioscience Reports · doi:10.1042/bsr20250362

Editorial: Neuroprotection and Disease Modification in Parkinson's Disease

Otero‐Losada, M., Gubellini, P., Capani, F., & Perez‐Lloret, S. (2021) · Greater South Information System · doi:10.60692/q8pnv-smx70

Ghrelin alleviates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells

Xue, Y., He, X., Yuan, W., Yang, C., Zhu, L., Liu, F., & Feng, J. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.314314 · Cited by 10 · see citing works

Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease

Rees, D. J., Beynon, A. L., Lelos, M. J., Smith, G. A., Roberts, L. D., Phelps, L., Dunnett, S. B., Morgan, A. H., Brown, M. R., Wells, T., et al. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01282-9 · Cited by 9 · see citing works

6-Hydroxydopamine induces autophagic flux dysfunction by impairing transcription factor EB activation and lysosomal function in dopaminergic neurons and SH-SY5Y cells

He, X., Yuan, W., Li, Z., Hou, Y., Liu, F., & Feng, J. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.11.017 · Cited by 36 · see citing works

Ghrelin protects dopaminergic neurons against MPTP neurotoxicity through promoting autophagy and inhibiting endoplasmic reticulum mediated apoptosis

Wang, H., Dou, S., Zhu, J., Shao, Z., Wang, C., & Cheng, B. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147023 · Cited by 33 · see citing works